Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




ADLM Issues Laboratory Guidance for Gender-Diverse Patient Care

By LabMedica International staff writers
Posted on 06 Jul 2026

Laboratory medicine increasingly intersects with gender-affirming care, where hormone therapy and rigid health record fields can complicate the interpretation of routine tests. More...

Without appropriate clinical context, changes in cardiac, kidney, and liver analytes may be difficult to classify, while missing organ-specific information can disrupt preventive screening. Additional gaps remain in transfusion workflows and autopsy documentation for gender-diverse patients. New findings describe U.S.-focused guidance designed to help clinical laboratories address these challenges.

The Association for Diagnostics & Laboratory Medicine (ADLM) has released a comprehensive guidance document detailing practical steps for laboratories and pathology services that care for gender-diverse adults. The document outlines a framework to interpret results influenced by gender-affirming hormone therapy and to improve electronic health record (EHR) workflows so results, flags, and reminders better reflect patient physiology. ADLM notes that prior recommendations from several U.S. medical societies have not broadly covered laboratory medicine and pathology, prompting the organization to convene clinical chemists, pathologists, endocrinologists, and clinicians who directly care for transgender patients.

The guidance centers on adults who have received gender-affirming hormone therapy for at least six months, where evidence is strongest. It advises moving away from a one‑size‑fits‑all use of reference intervals and toward interpretation that integrates physiology, hormone levels, and patient goals; for example, although some societies cite 100–200 pg/mL as a target estradiol concentration for transgender women, published data support a wider range when assessed in context. ADLM also recommends adoption of an EHR “organ inventory”—a checklist documenting organ presence and procedure dates—to sharpen result interpretation and ensure screening reminders remain appropriate.

Beyond chemistry and EHR optimization, the document calls for standardized, evidence‑based approaches in transfusion medicine for transgender and nonbinary donors and recipients to maintain safety and equity. It also provides direction for autopsy documentation, recommending use of the decedent’s chosen name and correct pronouns, recording both legal sex and affirmed gender identity, using gender‑neutral anatomic terminology, and noting evidence of gender‑affirming care without speculation. Collectively, these measures are intended to support more accurate, equitable, and patient‑centered services within the clinical laboratory.

“The interpretation of laboratory and pathology tests for gender-diverse patients remains an evolving area of medicine. As the evidence base continues to grow, laboratories, healthcare organizations, and researchers must work together to develop patient-centered approaches that support accurate test interpretation, respectful documentation, and equitable care,” stated the document authors.

Related Links
ADLM


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Electrolyte Analyzer
BKE-B
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.